3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Active not recruiting
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Pancreatic Neoplasms
2
Interventions
Specimen Handling
20
Gemcitabine
18
Magnetic Resonance Spectroscopy
12
Biopsy
12
Leucovorin
10
Irinotecan
10
Fluorouracil
10
130-nm albumin-bound paclitaxel
10
Albumin-Bound Paclitaxel
8
Oxaliplatin
7
Taxes
6
pembrolizumab
5
Nivolumab
5
irinotecan sucrosofate
4
fludarabine
4
dehydroftorafur
4
Radiosurgery
4
Ipilimumab
4
Cyclophosphamide
4
Capecitabine
4
aldesleukin
3
Radiotherapy
3
Radiation
3
Exercise
3
Cisplatin
3
Cetuximab
3
veliparib
2
trametinib
2
quemliclustat
2
palbociclib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
quemliclustat
×
30 days
×
Clear all
NCT06608927
2026-05-08
PRISM-1
Arcus Biosciences, Inc.
Phase 3
Active not recruiting
610 enrolled
NCT04104672
2026-05-07
ARC-8
Arcus Biosciences, Inc.
Phase 1
Active not recruiting
196 enrolled